Detalhe da pesquisa
1.
[Influence of the 2019-novel coronavirus pandemic on the management of breast cancer]. / Influencia de la pandemia por enfermedad por coronavirus 2019 en el manejo del cáncer de mama.
Clin Invest Ginecol Obstet
; 47(3): 89-90, 2020.
Artigo
em Espanhol
| MEDLINE | ID: mdl-32834304
2.
Overall survival benefit for sequential doxorubicin-docetaxel compared with concurrent doxorubicin and docetaxel in node-positive breast cancer--8-year results of the Breast International Group 02-98 phase III trial.
Ann Oncol
; 24(5): 1203-11, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23293111
3.
Exemestane as primary treatment of oestrogen receptor-positive breast cancer in postmenopausal women: a phase II trial.
Br J Cancer
; 100(3): 442-9, 2009 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-19156139
4.
[Dose intensity received in breast cancer treatment with chemotherapy]. / Intensidad de dosis recibida en el tratamiento quimioterápico del cáncer de mama.
Farm Hosp
; 31(5): 270-5, 2007.
Artigo
em Espanhol
| MEDLINE | ID: mdl-18052629